Arterial hypertension secondary to the application of 9-alpha-fluoroprednisolone ointments
Arnal, J.M.; Moneo, M.I.; Loris, C.
Anales Espanoles de Pediatria 26(1): 65-66
1987
ISSN/ISBN: 0302-4342 PMID: 3826948 Document Number: 293027
Document emailed within 1 workday
Related Documents
Rosselli, A.; Calacoci, S.; Regoli, G.; Turchi, A. 1985: Pseudohyperaldosteronism secondary to oral brushing of 9-alpha-fluoroprednisolone. Presentation of a clinical case Giornale di Clinica Medica 66(9-10): 359-362Andreassi, L.; Valentino, A. 1971: 9-alpha-fluoroprednisolone in lotion and ointment in topical dermatological therapy Minerva Medica 62(1): 42-46
Scarpa, C.; Gentilli, G. 1983: Hypokalemic alkalosis due to 9-alpha-fluoroprednisolone locally applied in pemphigus vulgaris Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 118(3): 179-181
Bischof Delaloye, A.; Delaloye, B. 1989: Radioisotope studies in secondary arterial hypertension Revue Medicale de la Suisse Romande 109(1): 17-24
Chamontin, B. 1994: Secondary arterial hypertension in adults. Etiology, physiopathology La Revue du Praticien 44(7): 953-959
Mikhin, V.P.; Kharchenko, A.V.; Rosliakova, E.A.; Cherniatina, M.A. 2011: Application of coenzyme Q(10) in combination therapy of arterial hypertension Kardiologiia 51(6): 26-31
Novikova, T.V.; Britov, A.N.; Aleksandrov, A.A.; Shchepkin, V. 1983: Inventory of socio-psychological factors in the secondary prevention of arterial hypertension Sovetskaia Meditsina 1983(1): 62-65
Britov, A.; Alexandrov, A.; Molchanov, V.; Novikova, T.; Prokhorov, A.; Litun, I. 1982: Psychological and occupational risk factors in the secondary prevention of the arterial hypertension Activitas Nervosa Superior Suppl. 3(Pt 2): 475
Rubio Barbon, S.; Alvarez Carreño, F.; de la Torre, R.; Velasco Alvarez, A. 1991: Arterial hypertension secondary to primary hyperaldosteronism caused by an adrenal adenoma Anales de Medicina Interna 8(7): 364-365
Elgarov, A.A.; Aramisova, R.M.; Elgarov, M.A.; Kalmykova, M.A. 2015: Secondary Prevention of Arterial Hypertension in Vehicle Drivers--Efficiency, Specific Safety Klinicheskaia Meditsina 93(4): 31-38
Forette, F.; Varin, D.; Henry, J.F.; Hervy, M.P. 1980: Treatment of arterial hypertension in the elderly with an alpha-blocker: nicergoline La Nouvelle Presse Medicale 9(48): 3685-3688
Santillana López, T.; De Andrés De Colsa, R.; Borrell Andrés, J.; Ruíz De Aguiar González, A. 1978: Male pseudohermaphroditism and arterial hypertension: defect in the 17-alpha hydroxylation Revista Clinica Espanola 149(5): 499-505
Eliseeva, N.A. 1982: Results of the primary and secondary prevention of arterial hypertension among women at an industrial enterprise in Moscow Kardiologiia 22(3): 69-73
Cloix, J.F.; Le Jossec, M.; Baud, O.; Pecquery, R.; Giudicelli, Y.; Dausse, J.P. 1992: Na+/H+ exchangers, alpha-2-adrenergic receptors, sodium sensitivity and arterial hypertension Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 186(4): 377-386
Forette, F.; Henry, J.F.; Hervy, M.P.; Henry-Amar, M.; Brugier, S. 1983: Treatment of arterial hypertension in aged subjects with an alpha-blocker: prazosin Therapie 38(4): 387-392
Sukhorukov, V.V.; Frolova, E.V.; Tereshina, O.V.; Krugomov, A.V.; Trofimov, S.I.; Goncharova, E.S. 2011: Endovascular treatment of a female patient with resistant arterial hypertension secondary to a renal artery aneurysm Angiologiia i Sosudistaia Khirurgiia 17(4): 49-52
Khvorostinka, V.N.; Pasieshvili, L.M.; Biazrova, V.V. 1992: The prevalence and secondary prevention of ischemic heart disease and arterial hypertension in workers of the gas recovery industry Likars'ka Sprava 1992(5): 80-82
Kishlar', L.I.; Botnar', V.I.; Glazunov, I.S. 1991: Epidemiological situation regarding arterial hypertension after conducting 5-year program of its secondary prevention among rural population of Moldavia Kardiologiia 31(3): 78-79
Zonis, B.Ia.; Brin, V.B. 1979: Changes of cardio- and hemodynamics during treatment of arterial hypertension with adrenergic alpha receptor blockader pyrroxane Terapevticheskii Arkhiv 51(11): 28-30
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311